What should the nurse educate the client regarding signs of bleeding while on ticlopidine hydrochloride?

When educating a client about the potential side effects of ticlopidine hydrochloride, it is crucial to focus on the signs of bleeding, as this medication is an antiplatelet agent that can increase the risk of bleeding by inhibiting platelet aggregation. Unexplained bruising or prolonged bleeding is a direct indication that the medication may be affecting the body's ability to clot properly. This includes situations where the client may experience bruises with minimal or no trauma or notice that cuts or abrasions take longer than usual to stop bleeding.

In contrast, increased thirst, nausea and vomiting, and swelling in the hands and feet are not indicative of bleeding. Increased thirst may suggest dehydration or other metabolic changes but does not relate to bleeding risk. Nausea and vomiting can be side effects of medications but do not necessarily indicate bleeding. Swelling in the hands and feet may signal fluid retention or allergic reactions, which are separate concerns from the hematological effects associated with ticlopidine.

Therefore, the focus on monitoring for unexplained bruising or prolonged bleeding is essential for ensuring client safety while taking this medication.